Page last updated: 2024-12-09

n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-(2-iodacetamido)-TEMPO : A piperidinecarboxamide that is TEMPO carrying an 2-iodoacetamido group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2724305
CHEBI ID180674
MeSH IDM0043958

Synonyms (24)

Synonym
CHEBI:180674
4-(2-iodacetamid)-2,2,6,6-tetramethylpiperidinyloxyl
4-(2-iodacetamido)-tempo
4-(2-iodacetamid)-2,2,6,6-tetramethylpiperidine-1-oxyl
iasl
4-(2-iodoacetamido)-tempo, free radical
4-(2-iodoacetamido)-2,2,6,6-tetramethylpiperidine 1-oxyl
I0487
4-(2-iodoacetamido)-tempo
25713-24-0
n-(oxyl-2,2,6,6-tetramethylpiperid-4-yl)iodoacetamide
n-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide
1-piperidinyloxy, 4-((iodoacetyl)amino)-2,2,6,6-tetramethyl-
n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide
tmpia
4-(2-iodoacetamido)-2,2,6,6-tetramethylpiperidine-1-oxyl
4-(n-iodoacetamide)-2,2,6,6-tetramethylpiperidine-1-oxyl
2,2,6,6-tetramethylpiperdin-n-1-oxyiodoacetamide
AKOS015916248
DTXSID30180405
mfcd00010171
4-(2-iodoacetamido)-2,2,6,6-tetramethylpiperidine 1-oxyl free radical
4-(2-iodoacetamido)-2,2,6,6,-tetramethyl-1-piperidinyloxy
4-(2-iodoacetamido)-2,2,6,6-tetramethylpiperidine 1-oxylfree radical
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
radical scavengerA role played by a substance that can react readily with, and thereby eliminate, radicals.
spin labelA role played by a stable paramagnetic group that is attached to a part of a molecular entity whose microscopic environment is of interest and may be revealed by the electron spin resonance (ESR) spectroscopy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
aminoxylsRadicals derived from hydroxylamines by removal of the hydrogen atom from the hydroxy group. The synonymous terms nitroxyl radicals and nitroxides erroneously suggest the presence of a nitro group.
organoiodine compoundAn organoiodine compound is a compound containing at least one carbon-iodine bond.
piperidinecarboxamide
secondary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (40.00)18.7374
1990's11 (55.00)18.2507
2000's1 (5.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.07 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]